By Andrea Anderson

SAN DIEGO (GenomeWeb News) – While genome-wide association studies have long been considered an avenue for improving diagnostics, prognostics, and treatment, their most immediate application appears to be for improving drug safety and decreasing adverse events, according to Lon Cardon, senior vice president of GlaxoSmithKline's genetics program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.